Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis

BACKGROUND: A 14-day course of primaquine is used for radical cure of Plasmodium vivax and Plasmodium ovale malaria only. We quantified the risk of P vivax parasitaemia after treatment of Plasmodium falciparum with commonly used antimalarial drugs to assess the potential benefits of radical cure for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Infect Dis
Autors principals: Commons, Robert J, Simpson, Julie A, Thriemer, Kamala, Hossain, Mohammad S, Douglas, Nicholas M, Humphreys, Georgina S, Sibley, Carol H, Guerin, Philippe J, Price, Ric N
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science ;, The Lancet Pub. Group 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300482/
https://ncbi.nlm.nih.gov/pubmed/30587297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(18)30596-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars